Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
BMC Surg. 2023 Aug 27;23(1):255. doi: 10.1186/s12893-023-02164-7.
To summarize and discuss the guiding role of endoscopic ultrasound (EUS) in selecting endoscopic treatments for submucosal tumors (SMTs) in the upper gastrointestinal tract.
A retrospective investigation was conducted on 156 SMT patients who received endoscopic resection guided by EUS in the endoscopy center of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine from May 2019 to September 2021. Next, the size, pathological type, and distribution of lesions were analyzed; the correlation of the tumor origin with distribution of lesions and selection of treatments was explored; and the consistency of preoperative EUS diagnosis and postoperative pathological diagnosis was summarized and analyzed.
The tumor diameters of the included SMT patients ranged from 0.3 to 4 cm, with a mean diameter of 0.95 cm; the lesions were mostly located in the esophagus, gastric fundus or fundic cardia and gastric body. As for the pathological types, liomyoma was the most common tumor in the esophagus, liomyoma and mesenchymoma were mainly located in the fundic cardia and gastric body, and heterotopic pancreas was mostly discovered in the gastric sinus. Among 38 esophageal SMT patients, some with lesions originating from muscularis mucosa and submucosa under EUS mainly underwent endoscopic submucosal dissection (ESD) and endoscope band ligation (EBL); while others with lesions originated from muscularis propria mainly received submucosal tunneling endoscopic resection (STER). Of 115 gastric SMT patients under EUS, some with lesion origins from the muscularis mucosa and submucosa mainly underwent endoscopic submucosal excavation (ESE), while others from muscularis propria mainly underwent ESE, ESD, and endoscopic full-thickness resection (EFTR). Besides, 3 duodenal SMT patients with lesion origins from submucosa and muscularis propria under EUS were given ESD and ESE, respectively. Additionally, 121 cases showed a consistency between the EUS diagnosis and the postoperative pathological nature, and the consistency rate was 84.6%.
Clarifying the origin layer, size, growth pattern, and pathological nature of the lesion through preoperative EUS can guide the precise selection of endoscopic treatments, thereby ensuring a safe, effective, and complete surgical outcomes and reducing complications.
总结和探讨内镜超声(EUS)在上消化道黏膜下肿瘤(SMT)内镜治疗中的指导作用。
回顾性分析 2019 年 5 月至 2021 年 9 月在广州中医药大学第二附属医院内镜中心接受 EUS 引导内镜下切除术的 156 例 SMT 患者。分析肿瘤大小、病理类型及病变分布;探讨肿瘤起源与病变分布及治疗方法选择的相关性;总结并分析术前 EUS 诊断与术后病理诊断的一致性。
纳入 SMT 患者的肿瘤直径为 0.3~4cm,平均直径为 0.95cm;病变主要位于食管、胃底或贲门和胃体。病理类型方面,食管以平滑肌瘤最常见,贲门和胃体以平滑肌瘤和间叶瘤为主,胃窦以异位胰腺为主。38 例食管 SMT 患者中,EUS 下黏膜下肌层和黏膜下层起源的部分病变主要行内镜黏膜下剥离术(ESD)和内镜套扎术(EBL);起源于固有肌层的部分病变主要行黏膜下隧道内镜切除术(STER)。115 例胃 SMT 患者中,EUS 下黏膜下肌层和黏膜下层起源的部分病变主要行内镜黏膜下挖除术(ESE),起源于固有肌层的部分病变主要行 ESE、ESD 和内镜全层切除术(EFTR)。另外,EUS 下黏膜下和固有肌层起源的 3 例十二指肠 SMT 患者分别行 ESD 和 ESE。此外,EUS 诊断与术后病理性质一致的有 121 例,符合率为 84.6%。
术前 EUS 明确病变的起源层、大小、生长方式和病理性质,可指导精准选择内镜治疗方法,确保手术安全、有效、完整,减少并发症。